magnesium sulfate has been researched along with Child Mental Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| David, AL; Mendonça, M; Morgan, AS; Thiele, N | 1 |
| Chen, YT; Chiu, HY; Chu, SM; Lin, HC; Lin, HY; Tsai, ML | 1 |
| Ambalavanan, N; Bann, CM; Bell, EF; Carlo, WA; Chawla, S; Gargano, M; Gentle, SJ; Heyne, RJ; Higgins, RD; Hintz, SR; Tan, S; Tita, A | 1 |
| Blanchard, C; Bushman, ET; Casey, B; Harper, LM; Harris, S; Ramani, M; Sinkey, RG; Tita, AT | 1 |
| Caritis, SN; Clark, EAS; Dudley, DJ; Hankins, GDV; Iams, JD; Malone, FD; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Reddy, UM; Rouse, DJ; Sorokin, Y; Wapner, RJ; Weiner, SJ | 1 |
| Buhimschi, C; Caritis, SN; Carpenter, M; Costantine, MM; Dudley, DJ; Jablonski, KA; Leveno, KJ; Malone, FD; Mercer, BM; O'sullivan, MJ; Peaceman, AM; Ramin, SM; Reddy, UM; Rouse, DJ; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
| Clark, E; Kamyar, M; Manuck, TA; Stoddard, GJ; Varner, MW | 1 |
| Morag, I; Schushan-Eisen, I; Siman-Tov, M; Simchen, M; Stern, O; Strauss, T; Yakubovich, D | 1 |
1 review(s) available for magnesium sulfate and Child Mental Disorders
| Article | Year |
|---|---|
Evidence base multi-discipline critical strategies toward better tomorrow for very preterm infants.
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Budesonide; Caffeine; Central Nervous System Stimulants; Chorioamnionitis; Continuous Positive Airway Pressure; Counseling; Decision Making, Shared; Enteral Nutrition; Evidence-Based Practice; Female; Glucocorticoids; Humans; Hypotension; Hypothermia; Infant; Infant, Extremely Premature; Infant, Newborn; Magnesium Sulfate; Neurodevelopmental Disorders; Parenteral Nutrition; Patient Care Team; Pregnancy; Premature Birth; Prenatal Care; Probiotics; Pulmonary Surfactants; Resuscitation; Tocolytic Agents | 2020 |
2 trial(s) available for magnesium sulfate and Child Mental Disorders
| Article | Year |
|---|---|
Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
Topics: Case-Control Studies; Cerebral Palsy; Child, Preschool; Female; Genetic Variation; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Receptors, Interleukin-6; Stillbirth | 2018 |
Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Topics: Adult; Cerebral Palsy; Chorioamnionitis; Female; Humans; Infant; Infant Mortality; Infant, Premature, Diseases; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Stillbirth | 2016 |
5 other study(ies) available for magnesium sulfate and Child Mental Disorders
| Article | Year |
|---|---|
Management and outcomes of extreme preterm birth.
Topics: Adult; Decision Making, Shared; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care, Neonatal; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Perinatal Care; Peripartum Period; Pregnancy; Premature Birth | 2022 |
Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children.
Topics: Adrenal Cortex Hormones; Child, Preschool; Databases, Factual; Female; Gestational Age; Humans; Infant; Infant Mortality; Infant, Extremely Premature; Infant, Newborn; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Pregnancy; Pregnancy Outcome; Prenatal Care; Prenatal Exposure Delayed Effects; Prospective Studies; United States | 2020 |
Head Circumference within the Normal Range and Neurodevelopmental Outcomes in Preterm Infants.
Topics: Cephalometry; Cerebral Palsy; Child Development; Follow-Up Studies; Head; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neurodevelopmental Disorders; Psychomotor Disorders; Randomized Controlled Trials as Topic; Reference Values; Regression Analysis | 2021 |
Sex-Specific Genetic Susceptibility to Adverse Neurodevelopmental Outcome in Offspring of Pregnancies at Risk of Early Preterm Delivery.
Topics: Case-Control Studies; Cerebral Palsy; Female; Genetic Predisposition to Disease; Humans; Infant; Interleukin-6; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Psychomotor Disorders; Sex Factors; Tocolytic Agents | 2020 |
Short-term morbidities and neurodevelopmental outcomes in preterm infants exposed to magnesium sulphate treatment.
Topics: Adult; Case-Control Studies; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Premature; Intensive Care Units, Neonatal; Israel; Linear Models; Magnesium Sulfate; Male; Morbidity; Motor Skills Disorders; Multivariate Analysis; Neurodevelopmental Disorders; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Time Factors | 2016 |